Learn about AI and using it with real world data to support due diligence, product development, and pharmacovigilance in the 505(b)(2) market to join the meeting click the button below
A virtual conference fully dedicated to furthering the understanding of Value Added Medicine development, approval and commercialization
Value Added Medicines are:
>60%OF ALL NEW DRUG APPROVALS
|
~20% - 90%LESS COSTLY TO DEVELOP
|
VAM Week is a novel approach to expanding awareness and understanding of Value Added Medicines
Hear from and interact with speakers from the FDA, Industry and Suppliers as they discuss important topics and areas in the development, approval and commercialization of medications utilizing FDA's 505(b)(2) Pathway.
Registration Types
Review the agenda, choose a registration type, receive attendance information and codes
Single Session Registration
Use the Single Session for each sessions you would like to register for up to up to 4 separate sessions. Before Value Added Medicines (VAM) Week you will receive email invitations for each session. Please note when choosing multiple sessions you are not limited to one track and may choose sessions from either track.
5 Session Registration
Sold out
Purchase 5 sessions and save 20% off a single session registration. Before Value Added Medicines Week you will receive Zoom invitations with admission links to your selected sessions. Please note when choosing multiple sessions you are not limited to one track and may choose sessions from either track.
Sign up for 1 session for $50
Or as many sessions as you want
Sign up for 5 sessions and receive a 20% discount
Sign up for all 10 sessions and receive a 30% discount
Sign up 5 people for all 10 sessions and receive a astounding 50% discount
Or as many sessions as you want
Sign up for 5 sessions and receive a 20% discount
Sign up for all 10 sessions and receive a 30% discount
Sign up 5 people for all 10 sessions and receive a astounding 50% discount
repurposed |
Identifying a new use for an already approved pharmaceutical product that is outside the scope of the original medical indication
|
reformulated |
Developing a different formulation for an already approved pharmaceutical product
|
repositioned |
Moving an existing and marketed pharmaceutical product from one regulatory class to another
|
reauthorized |
Gaining authorization in the US for a pharmaceutical product already in use in another ex-US market.
|